These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1130406)

  • 1. LETTER: Safety of various intravenous solution systems.
    Wood WA
    Am J Hosp Pharm; 1975 Apr; 32(4):359. PubMed ID: 1130406
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbial contamination of glass bottle (open-vented) and plastic bag (closed-nonvented) intravenous fluid delivery systems.
    Poretz DM; Guynn JB; Duma RJ; Dalton HP
    Am J Hosp Pharm; 1974 Aug; 31(8):726-32. PubMed ID: 4604770
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the safety and efficiency of three intermittent intravenous therapy systems--the minibottle, the minibag and the inline burette.
    McAllister JC; Buchanan EC; Skolaut MW
    Am J Hosp Pharm; 1974 Oct; 31(10):961-7. PubMed ID: 4216266
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of pH, time, temperature, and autoclaving on E. coli endotoxin in selected parenteral solutions.
    Mosier LD; Bosworth ME; Jurgens RW; Mohl MH; Rizzolo RR
    J Parenter Sci Technol; 1987; 41(1):21-5. PubMed ID: 3550027
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Harmful effects of particles in intravenous infusions.
    Myers JA
    Am J Hosp Pharm; 1975 Jan; 32(1):11. PubMed ID: 1124773
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions between drugs and plastic intravenous fluid bags. II. Leaching of chemicals from bags containing various solvent media.
    Moorhatch P; Chiou WL
    Am J Hosp Pharm; 1974 Feb; 31(2):149-52. PubMed ID: 4815847
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diprivan-EDTA--choice in favor of patients safety].
    Ovechkin AM; Gagarina IuV
    Anesteziol Reanimatol; 2002; (3):52-6. PubMed ID: 12221880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CIRS-AINS special: particle contamination after drawing drugs - a relevant problem with a solution].
    Günther W; Hahnenkamp C; Rhaiem T; Schleppers A; St Pierre M
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(4-5):352-5. PubMed ID: 24066374
    [No Abstract]   [Full Text] [Related]  

  • 9. Air bubble barrier to syringe contamination.
    Magjsoudi B
    Anaesthesia; 2006 Mar; 61(3):305-6. PubMed ID: 16480373
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Contamination of Con A Preparations.
    Fumarola D; Jirillo E
    J Immunol; 1976 Apr; 116(4):1197. PubMed ID: 1254968
    [No Abstract]   [Full Text] [Related]  

  • 11. Minimizing human intervention in intravenous admixture practice.
    Tribble DA
    Am J Health Syst Pharm; 2010 Mar; 67(5):389-90. PubMed ID: 20172990
    [No Abstract]   [Full Text] [Related]  

  • 12. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report: biosafety analysis of one-way backflow valves for multiple patient use of low osmolar intravenous contrast solution.
    Can Commun Dis Rep; 1996 Feb; 22(4):28-31. PubMed ID: 9053058
    [No Abstract]   [Full Text] [Related]  

  • 14. [The study about the source, harmfulness and preventive measures of indissoluble particles in injection].
    Tang LM
    Zhongguo Yi Liao Qi Xie Za Zhi; 2001 Nov; 25(6):359-61. PubMed ID: 12583274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiographic contrast media conservation systems.
    Health Devices; 1996 Nov; 25(11):400-12. PubMed ID: 8913779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particles in intravenous solutions: a review.
    Thomas WH; Lee YK
    N Z Med J; 1974 Aug; 80(522):170-8. PubMed ID: 4608302
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Volume control sets and incompatibilities.
    Jansen JR
    Am J Hosp Pharm; 1975 Dec; 32(12):1225. PubMed ID: 1211393
    [No Abstract]   [Full Text] [Related]  

  • 18. Contamination control in contract filling of small volume parenterals.
    Sherman NE
    Bull Parenter Drug Assoc; 1970; 24(3):148-52. PubMed ID: 5422903
    [No Abstract]   [Full Text] [Related]  

  • 19. [Control of foreign particle contamination of injectable solutions].
    Van Ooteghem M; Moës A
    J Pharm Belg; 1972; 27(4):493-504. PubMed ID: 4681079
    [No Abstract]   [Full Text] [Related]  

  • 20. [Various aspects of production of a therapeutic form of liposomal cytarabine].
    Pleteneva OP; Oksinoĭd OE; Afonin NI
    Vestn Akad Med Nauk SSSR; 1990; (8):33-4. PubMed ID: 2275274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.